Headache Syndromes: Primary and Secondary Headache Disorders

Headache is one of the most common neurological complaints, affecting nearly 90% of the population at some point in their lives. The International Classification of Headache Disorders (ICHD-3) provides a comprehensive framework for diagnosing headache syndromes, dividing them into three main categories: primary headache disorders, secondary headache disorders, and painful cranial neuropathies.

Primary headache disorders account for approximately 95% of all headaches and include migraine, tension-type headache, cluster headache, and other trigeminal autonomic cephalalgias. These disorders are not caused by underlying structural or systemic pathology but represent the primary disease process itself.

Secondary headache disorders result from underlying pathology such as intracranial lesions, infections, vascular disorders, or medication overuse. While less common (5% of cases), they require immediate attention as they may be life-threatening.

Clinical Assessment Framework:

Headache Patient ↓ Obtain detailed history:

• Onset (sudden vs gradual)
• Duration and frequency
• Location and quality
• Associated symptoms
• Triggers and relieving factors
• Previous headache history ↓ Physical examination:
• Vital signs
• Neurological examination
• Fundoscopy
• Neck stiffness ↓ Red flag assessment ↓ Classification: Primary vs Secondary

The approach to headache diagnosis relies heavily on pattern recognition and careful history-taking. The mnemonic SNOOP helps identify concerning features: Systemic symptoms/illness, Neurological symptoms, Onset sudden, Older age (>50 years), Pattern change or papilledema.

Timing is crucial in headache evaluation. Thunderclap headaches (reaching maximum intensity within seconds to minutes) require immediate investigation for subarachnoid hemorrhage. Progressive headaches over weeks to months may suggest space-occupying lesions, while chronic daily headaches often represent medication overuse or transformed migraine.

The prevalence of primary headache disorders varies significantly: tension-type headache affects 70-80% of the population, migraine affects 12-15%, and cluster headache affects 0.1-0.4%. Understanding these epidemiological patterns helps inform diagnostic probability and guides clinical decision-making.

Migraine is a complex neurovascular disorder characterized by recurrent episodes of moderate to severe headache, often accompanied by autonomic and neurological symptoms. The pathophysiology involves trigeminovascular system activation, cortical spreading depression, and neurotransmitter dysfunction, particularly involving serotonin, CGRP (calcitonin gene-related peptide), and dopamine.

ICHD-3 Diagnostic Criteria for Migraine Without Aura: A. At least 5 attacks fulfilling criteria B-D B. Headache attacks lasting 4-72 hours (untreated) C. At least 2 of the following characteristics:

• Unilateral location
• Pulsating quality
• Moderate to severe intensity
• Aggravation by routine physical activity D. At least 1 of the following during headache:
• Nausea and/or vomiting
• Photophobia and phonophobia

Migraine Phases:

Migraine Aura occurs in 25-30% of migraine patients and typically precedes the headache phase. Visual auras are most common (90%), presenting as scintillating scotomas, fortification spectra, or homonymous visual field defects. Sensory auras manifest as paresthesias spreading from fingers to arm to face. Motor auras are rare but may occur in hemiplegic migraine.

Migraine Triggers include dietary factors (aged cheese, chocolate, alcohol), hormonal changes (menstruation, oral contraceptives), environmental factors (bright lights, strong odors), stress, sleep pattern changes, and weather changes. Identifying and avoiding triggers is an important aspect of migraine management.

Chronic Migraine is defined as headache occurring ≥15 days per month for >3 months, with migraine features on ≥8 days per month. This condition significantly impacts quality of life and often requires preventive therapy. The transformation from episodic to chronic migraine may be facilitated by medication overuse, obesity, depression, and stressful life events.

Tension-Type Headache (TTH) is the most prevalent primary headache disorder, characterized by bilateral, pressing or tightening pain of mild to moderate intensity. Unlike migraine, TTH typically lacks associated autonomic symptoms and is not aggravated by routine physical activity.

ICHD-3 Diagnostic Criteria for Episodic Tension-Type Headache: A. At least 10 episodes fulfilling criteria B-D B. Headache lasting 30 minutes to 7 days C. At least 2 of the following characteristics:

• Bilateral location
• Pressing/tightening quality
• Mild to moderate intensity
• Not aggravated by routine physical activity D. Both of the following:
• No nausea or vomiting
• No more than one of photophobia or phonophobia

TTH Pathophysiology involves peripheral mechanisms (myofascial nociception from pericranial muscles) and central sensitization in chronic forms. Stress, anxiety, depression, and sleep disorders are common comorbidities that may perpetuate the condition.

Cluster Headache represents the most severe primary headache disorder, characterized by excruciating unilateral pain with associated ipsilateral autonomic features. It affects men more than women (3:1 ratio) and typically begins in the third decade of life.

ICHD-3 Diagnostic Criteria for Cluster Headache: A. At least 5 attacks fulfilling criteria B-D B. Severe or very severe unilateral orbital, supraorbital, and/or temporal pain lasting 15-180 minutes C. Either or both of the following:

• At least one of the following ipsilateral symptoms:
  • Conjunctival injection and/or lacrimation
  • Nasal congestion and/or rhinorrhea
  • Eyelid edema
  • Forehead and facial sweating
  • Miosis and/or ptosis
• Sense of restlessness or agitation D. Attack frequency: 1 every other day to 8 per day

Cluster Headache Patterns:

Episodic Cluster Headache (90%) ↓ Cluster periods: weeks to months ↓ Remission periods: months to years

Chronic Cluster Headache (10%) ↓ Attacks for >1 year without remission ↓ Or remissions <3 months

Cluster headache attacks follow circadian rhythms, often occurring at the same time daily, frequently awakening patients from sleep. Alcohol is a potent trigger during cluster periods but not during remission phases. The pathophysiology involves hypothalamic dysfunction, trigeminal-autonomic reflex activation, and possible genetic factors.

Secondary headaches result from underlying pathology and require prompt recognition and treatment. While representing only 5% of all headaches, they may be life-threatening if undiagnosed. The key to identification lies in recognizing red flag features that distinguish secondary headaches from benign primary headache disorders.

Major Red Flags for Secondary Headache:

SNOOP4 Mnemonic:

• Systemic symptoms (fever, weight loss, night sweats)
• Neurological symptoms or abnormal signs
• Onset sudden (thunderclap headache)
• Onset in older patients (>50 years)
• Pattern change or progression
• Positional component
• Precipitated by Valsalva or exertion
• Papilledema or visual changes

Critical Secondary Headache Syndromes:

Thunderclap Headache Evaluation:

Thunderclap headache ↓ Immediate CT head ↓ If normal and high suspicion: ↓ Lumbar puncture ↓ If normal: CT angiography

Age-Related Considerations:

• <5 years: Rarely primary headache; consider intracranial pressure, infection
• 5-18 years: Migraine common, but consider brain tumor if progressive
• >50 years: New-onset headache warrants investigation for secondary causes
• >65 years: Giant cell arteritis, medication effects, cervical spine disease

Medication Overuse Headache (MOH) occurs with regular overuse of acute headache medications for >3 months. Simple analgesics (aspirin, acetaminophen, NSAIDs) require use ≥15 days/month, while triptans, opioids, or combination medications require use ≥10 days/month. MOH creates a vicious cycle where medication withdrawal triggers rebound headaches, leading to further medication use.

The diagnostic approach to headache disorders relies primarily on clinical assessment, with neuroimaging reserved for specific indications. Most primary headache disorders are diagnosed based on clinical criteria without need for additional testing. However, appropriate use of diagnostic studies is crucial when red flags are present.

Neuroimaging Indications - American College of Radiology Guidelines:

Urgent Brain MRI/CT Required:

• Sudden-onset severe headache (thunderclap)
• Headache with fever and nuchal rigidity
• Headache with focal neurological signs
• Headache with altered mental status
• Headache with papilledema
• New headache in immunocompromised patient
• Headache after head trauma

Brain MRI Preferred (Non-urgent):

• New-onset headache in patient >50 years
• Progressive headache over weeks/months
• Headache with atypical features
• Change in headache pattern
• Headache triggered by Valsalva maneuver
• History of malignancy with new headache

Diagnostic Algorithm for Headache Workup:

Headache Patient ↓ Detailed History + Physical Exam ↓ Red Flags Present? ↓ ↓ YES NO ↓ ↓ Urgent imaging Primary headache likely ↓ ↓ CT/MRI brain Apply diagnostic criteria ↓ ↓ Abnormal Migraine/TTH/Cluster ↓ ↓ Treat underlying Initiate appropriate cause management

Laboratory Studies: Routine laboratory tests are generally not indicated for primary headache disorders. However, specific tests may be warranted based on clinical presentation:

• ESR/CRP: If giant cell arteritis suspected (age >50, temporal tenderness)
• Complete Blood Count: If systemic illness suspected
• Comprehensive Metabolic Panel: If medication toxicity or metabolic cause suspected
• Thyroid Function: If hyperthyroidism suspected
• Lumbar Puncture: If meningitis or subarachnoid hemorrhage suspected with normal CT

Lumbar Puncture Indications:

• Suspected meningitis (fever, nuchal rigidity, altered mental status)
• Thunderclap headache with normal CT scan
• Suspected idiopathic intracranial hypertension
• Suspected carcinomatous meningitis

CSF Analysis in Headache Disorders:

Imaging should be interpreted in the clinical context, as incidental findings are common in asymptomatic individuals. Up to 2% of asymptomatic adults have incidental aneurysms on MRI, and white matter lesions increase with age.

Management of primary headache disorders involves both acute (abortive) and preventive (prophylactic) strategies. Treatment selection depends on headache frequency, severity, disability, and patient-specific factors including comorbidities and medication tolerance.

Migraine Treatment Algorithm:

Acute Treatment:

Mild-Moderate Migraine ↓ NSAIDs/Acetaminophen

• Antiemetic if needed ↓ If inadequate response: ↓ Triptan + NSAID

Moderate-Severe Migraine ↓ Triptan (first-line)

• Antiemetic if needed ↓ If contraindicated: ↓ DHE or Lasmiditan

Triptan Selection and Dosing:

Contraindications to Triptans:

• Coronary artery disease or vasospastic angina
• Cerebrovascular disease
• Peripheral vascular disease
• Uncontrolled hypertension
• Hemiplegic or basilar migraine

Preventive Treatment Indications:

• ≥4 headache days per month
• ≥8 headache days per month with some disability
• Failure of acute treatments
• Frequent use of acute medications
• Special circumstances (hemiplegic migraine, migrainous infarction)

Migraine Prevention Medications:

Tension-Type Headache Management:

Acute Treatment:

• First-line: NSAIDs (ibuprofen 400-800 mg, naproxen 220-440 mg)
• Second-line: Acetaminophen 1000 mg
• Combination analgesics (avoid for frequent use)

Chronic TTH Prevention:

• Amitriptyline 10-75 mg daily (first-line)
• Mirtazapine 15-30 mg daily
• Topiramate 50-200 mg daily

Cluster Headache Management:

Acute Treatment:

Cluster Attack ↓ High-flow oxygen 15 L/min × 15-20 min OR Subcutaneous sumatriptan 6 mg ↓ If inadequate: ↓ Intranasal zolmitriptan 5-10 mg

Cluster Prevention:

• Verapamil 240-480 mg daily (first-line)
• Lithium 600-900 mg daily (monitor levels)
• Topiramate 100-200 mg daily
• Greater occipital nerve block for transitional therapy

Certain headache presentations require immediate recognition and management due to their potential for serious complications or death. Understanding these emergency scenarios and appropriate management strategies is crucial for all healthcare providers.

Status Migrainosus is defined as a debilitating migraine attack lasting >72 hours despite treatment. It may lead to dehydration, medication overuse, and significant disability.

Management Protocol:

Status Migrainosus ↓ IV hydration + antiemetics ↓ IV medications:

• DHE 0.5-1 mg IV q8h
• Metoclopramide 10 mg IV
• Ketorolac 30-60 mg IV ↓ If refractory: ↓ IV corticosteroids (Dexamethasone 4-8 mg)

Thunderclap Headache Differential:

• Subarachnoid hemorrhage (85% of cases)
• Cerebral venous thrombosis
• Posterior reversible encephalopathy syndrome (PRES)
• Cervical artery dissection
• Acute hypertensive crisis
• Primary thunderclap headache (diagnosis of exclusion)

Subarachnoid Hemorrhage (SAH) Management:

Suspected SAH ↓ Immediate CT head ↓ If positive: Neurosurgery consult ↓ If negative but high suspicion: ↓ Lumbar puncture ↓ If positive: CTA or conventional angiography

Giant Cell Arteritis (Temporal Arteritis): This represents a medical emergency due to risk of permanent visual loss. Suspect in patients >50 years with new-onset headache, jaw claudication, scalp tenderness, or visual symptoms.

Diagnostic Approach:

• ESR >50 mm/hr (often >100 mm/hr)
• CRP elevated
• Temporal artery biopsy (within 2 weeks of steroid initiation)
• Consider temporal artery ultrasound

Treatment: Immediate high-dose corticosteroids (prednisone 1 mg/kg/day or methylprednisolone 1 g IV daily × 3 days if visual symptoms)

Pregnancy and Headache: Migraine often improves during pregnancy, particularly in the second and third trimesters. However, new-onset headache during pregnancy requires careful evaluation.

Pregnancy-Specific Considerations:

• Pre-eclampsia/eclampsia
• Cerebral venous thrombosis
• Postdural puncture headache
• Pituitary apoplexy

Safe Medications in Pregnancy:

• Acute: Acetaminophen, metoclopramide
• Prevention: Low-dose aspirin, certain beta-blockers
• Avoid: NSAIDs (especially third trimester), triptans, ergots, valproate

Pediatric Headache Considerations:

• Migraine often bilateral in children
• Shorter duration (1-48 hours)
• Associated symptoms may be prominent
• Consider brain tumor if progressive headache with morning vomiting
• School absence and disability assessment important

Post-Traumatic Headache: Develops within 7 days of head trauma or regaining consciousness. May resemble tension-type or migraine. Usually resolves within 3 months but can become chronic. Management focuses on symptom control and gradual activity resumption.